Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

352
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
352
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

340
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
340
Relative Risk01:12

Relative Risk

505
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
505
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

634
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
634
Region of Convergence of Laplace Tarnsform01:20

Region of Convergence of Laplace Tarnsform

765
The Region of Convergence (ROC) is a fundamental concept in signal processing and system analysis, particularly associated with the Laplace transform. The ROC represents an area in the complex plane where the Laplace transform of a given signal converges, determining the transform's applicability and utility.
Consider a decaying exponential signal that begins at a specific time. When deriving its Laplace transform, the time-domain variable is replaced with a complex variable. This...
765
Odds Ratio01:09

Odds Ratio

368
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
368

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same author

Generalized win-odds regression models for composite endpoints.

Lifetime data analysis·2026
Same author

Plasma brain-derived tau: analytical and clinical validation of the first commercial immunoassay.

medRxiv : the preprint server for health sciences·2025
Same author

<i>APOE</i> Genotype-Stratified Meta-Analysis of Cognitive Decline Reveals Novel Loci for Language and Global Cognitive Function in Older Adults.

International journal of molecular sciences·2025
Same author

Comparison of visual and analytic methods of Alzheimer's disease pathologic staging.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Relationship between extracranial carotid artery calcification and amyloid-β deposition in the brain among the very old: A retrospective study.

Journal of Alzheimer's disease reports·2025

Related Experiment Video

Updated: Oct 12, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Prognostic accuracy for predicting ordinal competing risk outcomes using ROC surfaces.

Song Zhang1, Yang Qu2, Yu Cheng3

  • 1Department of Biostatistics, University of Pittsburgh, Pennsylvania, PA, 15260, USA.

Lifetime Data Analysis
|November 22, 2021
PubMed
Summary

This study introduces new methods to measure biomarker accuracy for predicting disease progression, extending receiver operating characteristic (ROC) surface and volume under the surface (VUS) concepts for complex health outcomes.

Keywords:
Concordance probabilityCorrect classification probabilityDiscriminative capabilityDisease progressionInverse probability of censoring weighting

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

420

Related Experiment Videos

Last Updated: Oct 12, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

420

Area of Science:

  • Biostatistics
  • Medical Informatics
  • Clinical Epidemiology

Background:

  • Biomarkers are crucial for tracking disease progression, but evaluating their predictive accuracy for sequential events is challenging.
  • Existing methods often fall short when dealing with ordinal outcomes and competing risks.

Purpose of the Study:

  • To extend receiver operating characteristic (ROC) surface and volume under the surface (VUS) concepts for ordinal competing-risk outcomes.
  • To develop and evaluate novel VUS estimators for biomarker accuracy assessment in complex clinical scenarios.

Main Methods:

  • Developed two VUS estimators: one integrating the ROC surface, another using inverse probability weighting.
  • Utilized counting process techniques and U-statistics theory for asymptotic analysis.
  • Validated methods through simulations and real-world data from cognition and transplant studies.

Main Results:

  • The proposed VUS estimators demonstrate good practical performance in simulations.
  • The methods effectively assess biomarker accuracy for predicting sequential, ordinal, and competing-risk outcomes.
  • Applications highlight the utility in analyzing complex medical data.

Conclusions:

  • The extended VUS framework provides a robust tool for evaluating biomarker accuracy in disease progression.
  • These methods enhance the ability to predict complex health trajectories using biomarker data.
  • The study offers valuable statistical approaches for clinical research and biomarker development.